Page last updated: 2024-08-17

aspartic acid and Idiopathic Parkinson Disease

aspartic acid has been researched along with Idiopathic Parkinson Disease in 84 studies

Research

Studies (84)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (7.14)	18.7374
1990's	23 (27.38)	18.2507
2000's	26 (30.95)	29.6817
2010's	25 (29.76)	24.3611
2020's	4 (4.76)	2.80

Authors

Authors	Studies
Alger, JR; Bui, V; Choupan, J; Donahue, EK; Duran, JJ; Foreman, RP; Jakowec, MW; O'Neill, J; Petzinger, GM; Van Horn, JD; Venkadesh, S	1
Annunziato, L; Della Notte, S; Scorziello, A; Secondo, A; Sisalli, MJ; Ventra, C	1
Du, N; Song, Z; Yuan, M	1
Butterfield, DA; Hinchie, A; Powell, DK; Ren, X; Swomley, A	1
Chaudhary, S; Goyal, V; Jagannathan, NR; Kalaivani, M; Kaloiya, GS; Kumaran, SS; Mehta, N; Sagar, R; Srivastava, AK	1
Arabia, G; Barbagallo, G; Caracciolo, M; Cherubini, A; Morelli, M; Nisticò, R; Novellino, F; Quattrone, A; Rocca, F; Sabatini, U; Salsone, M	1
Moriya, M; Nojo, T; Waragai, M	1
Robertson, DS	1
Gröger, A; Klose, U; Kolb, R; Schäfer, R	1
Bergamaschi, MM; Chagas, MH; Crippa, JA; dos Santos, AC; Hallak, JE; Pena-Pereira, MA; Sobreira, ET; Teixeira, AL; Tumas, V; Zuardi, AW	1
Bramanti, P; Ciurleo, R; Di Lorenzo, G; Marino, S	1
Bonanno, L; Bramanti, P; Ciurleo, R; Di Lorenzo, G; Marino, S	1
Öz, G	1
Bao, F; Caon, C; Chorostecki, J; George, E; Gorden, V; Khan, O; Krstevska, S; Santiago, C; Seraji-Bozorgzad, N; Zak, I	1
Almuqbel, M; Anderson, TJ; Dalrymple-Alford, JC; Keenan, RJ; Livingston, L; MacAskill, MR; Melzer, TR; Myall, DJ; Pitcher, TL; Wood, KL	1
Chen, J; Huang, MH; Liu, Y; Shen, YJ; Wu, G; Xing, Z	1
Auburger, G; Azizov, M; Bonin, M; Gasser, T; Gispert, S; Hoepken, HH; Klinkenberg, M; Kögel, D; Kurz, A; Morales-Gordo, B; Ricciardi, F; Riess, O; Steinmetz, H	1
Bardien, S; Carr, J; Keyser, R; Lombard, D; Yako, Y	1
Camicioli, RM; Gee, M; Hanstock, CC; Martin, WR; Wieler, M	1
den Hollander, JA; Griffith, HR; Marson, DC; O'Brien, T; Okonkwo, OC; Watts, RL	1
Fan, Z; Feany, MB; Hyman, BT; McFarland, NR; McLean, PJ; Schwarzschild, MA; Xu, K	1
Rajasankar, S; Surendran, S	1
Barker, GJ; Blain, CR; Guevara, CA; Leigh, PN; Lythgoe, DJ; Stahl, D	1
Austin, PJ; Betts, MJ; Broadstock, M; Duty, S; Mitchell, SN; O'Neill, MJ	1
Berg, D; Chadzynski, G; Godau, J; Gröger, A; Klose, U	1
Cuellar-Baena, S; Dahlberg, C; Denisov, V; Hall, H; In't Zandt, R; Kirik, D	1
Cao, L; Chen, S; Chen, SD; Liu, J; Ma, JF; Rong, TY; Wang, G; Wang, Y; Xiao, Q; Zhang, Y	1
Baudrexel, S; Berg, D; Brockmann, K; Csoti, I; Gasser, T; Hattingen, E; Hauser, AK; Hilker, R; Magerkurth, J; Merten, CD; Pilatus, U; Schulte, C; Srulijes, K	1
Duffy, S; Halliday, G; Lewis, SJ; Naismith, SL; Shine, JM	1
Fukazawa, Y; Mito, Y; Tajima, Y; Yanai, M	1
Ando, M; Funayama, M; Hashimoto, T; Hatano, T; Hattori, N; Ishizu, N; Kashihara, K; Kokubo, Y; Kuzuhara, S; Li, Y; Murakami, Y; Nakano, N; Noguchi, K; Ogaki, K; Sasaki, R; Tomiyama, H; Toyoda, C; Yamashita, C; Yoshino, H	1
Delfino, M; García-Sánchez, C; Gironell, A; Gómez-Ansón, B; Kulisevsky, J; Llebaria, G; Pagonabarraga, J; Pascual-Sedano, B; Rotger, R; Ruscalleda, J	1
Gan, R; Huang, B; Huang, Z; Nie, K; Wang, L; Zhang, Y; Zhao, J	1
Burgunder, J; Cao, B; Chen, K; Chen, X; Chen, Y; Guo, X; Huang, R; Li, J; Shang, HF; Song, W; Zhao, B	1
Aasly, J; Axelson, D; Bakken, IJ; Ehrnholm, B; Nilsen, G; Susann Gribbestad, I	1
Firbank, MJ; Harrison, RM; O'Brien, JT	1
Rottenberg, DA	1
Bianchi, L; Bolam, JP; Della Corte, L; Galeffi, F	1
Baik, HM; Choe, BY; Jeun, SS; Kim, BS; Kim, MC; Lee, HK; Lee, JM; Lee, KS; Son, BC; Suh, TS	1
Liu, Y; Ruan, LX; Shang, DS; Yuan, M; Zhang, LJ; Zheng, XN; Zhu, XC	1
Bastos, AC; Camicioli, RM; Emery, DJ; Fisher, NJ; Foster, SL; Hanstock, CC; Korzan, JR	1
Fukatsu, H; Hamada, K; Hirayama, M; Ishigaki, T; Katsuno, M; Okada, Y; Sobue, G; Sugiura, M; Watanabe, H	1
Afridi, S; Andrews, H; Clark, LN; Cote, LJ; Fahn, S; Ford, B; Frucht, S; Harris, J; Louis, ED; Marder, K; Mayeux, R; Mejia-Santana, H; Nicolai, A; Ottman, R; Strug, L; Waters, C	1
Chen, L; Feany, MB	1
Mignon, LJ; Wolf, WA	1
Dincer, A; Hanoglu, L; Meral, H; Ozer, F	1
Aia, P; Gruetter, R; Lowary, J; Oz, G; Terpstra, M; Tkác, I; Tuite, PJ	1
Akbas, N; Bauer, P; Behnke, S; Berg, D; Deplazes, J; Hochstrasser, H; Riess, O; Tomiuk, J; Walter, U	1
Durif, F; Fraix, V; Kickler, N; Krack, P; Krainik, A; Lamalle, L; Lebas, JF; Pollak, P; Rémy, C; Segebarth, C	1
Berti, C; Bianchi, MC; Bonuccelli, U; Ceravolo, R; Del Dotto, P; Gambaccini, G; Logi, C; Lucetti, C; Murri, L; Rossi, G; Tosetti, M	1
Balas, I; Dóczi, TP; Kovacs, N; Llumiguano, C; Schwarcz, A; Usprung, Z	1
Arosio, P; Biasiotto, G; Finazzi, D; Goldwurm, S; Pezzoli, G; Sironi, F; Tunesi, S; Zecchinelli, A	1
McLennan, H	1
Berl, S; Plaitakis, A	1
Mizuno, Y; Tanaka, Y	1
Heerschap, A; Hinshaw, DB; Holshouser, BA; Kolem, H; Komu, M; Masur, H; Möller, HE; Sonninen, P; Vermathen, P; Zijlmans, J	1
Barker, GJ; Davie, CA; Kingsley, DP; Lees, AJ; Miller, PH; Pirtosek, Z	1
Barker, GJ; Davie, CA; Kendall, BE; Marsden, CD; McDonald, WI; Miller, DH; Quinn, N; Tofts, PS; Wenning, GK	1
de Koster, A; Heerschap, A; Horstink, MW; Thijssen, HO; van 't Hof, MA; Zijlmans, JC	1
Block, RE; Bowen, BC; Lampman, DA; Murdoch, JB; Pattany, PM; Quencer, RM; Sanchez-Ramos, J	1
Barker, GJ; Brennan, A; Davie, CA; Miller, DH; Quinn, N; Wenning, GK	1
Akiguchi, I; Handa, J; Inubushi, T; Matsuda, M; Morikawa, S; Shiino, A	1
Chaudhuri, KR; Leigh, PN; Lemmens, G; Williams, SC	1
Arenas, J; Benito-León, J; Cisneros, E; Gasalla, T; Gómez, P; Jiménez-Jiménez, FJ; Molina, JA; Navarro, JA; Ortí-Pareja, M; Vargas, C	1
Aotsuka, A; Hattori, T; Shinotoh, H	1
De Mari, M; Federico, F; Giannini, P; Iliceto, G; Lamberti, P; Lucivero, V; Mezzapesa, DM; Simone, IL	1
Clarke, CE; Horsman, A; Lowry, M	1
Chaudhuri, KR; Dawson, J; Ellis, CM; Leigh, PN; Lemmens, G; Simmons, A; Williams, SC	1
Aminoff, MJ; Cruz, CJ; Graham, SH; Meyerhoff, DJ; Weiner, MW	1
Bertolino, A; Bonavita, S; Hallett, M; Litvan, I; Lundbom, N; Patronas, NJ; Tedeschi, G	1
De Mari, M; Federico, F; Giannini, P; Iliceto, G; Lamberti, P; Lucivero, V; Mezzapesa, DM; Simone, IL; Tarantino, A	1
Choe, BY; Kim, BS; Kim, MC; Lee, HK; Lee, KS; Park, JW; Shinn, KS; Son, BC; Suh, TS	1
Akiyama, H; Arai, T; Ikeda, K; Kondo, H; Mori, H	1
Bhattacharya, S; Brooks, DJ; Bryant, DJ; Cox, IJ; Sargentoni, J; Seery, JP; Taylor-Robinson, SD; Turjanski, N	1
Blüml, S; Dubowitz, D; Hoang, TQ; Jacques, DB; Kopyov, OV; Lin, A; Ross, BD; Seymour, K; Tan, J	1
Im, JH; Jeong, Y; Kim, HS; Kim, JS; Sohn, YH	1
Clarke, CE; Lowry, M	1
Bernardini, S; Bianchi, MC; Bonuccelli, U; Del Dotto, P; Gambaccini, G; Lucetti, C; Tosetti, M	1
Ikeda, K; Iwasaki, Y; Kinoshita, M; Shiojima, T	1
Carlsson, A; Carlsson, M	1
Bonham, JR; Candy, JM; Marshall, E; Perry, EK; Perry, RH; Xuereb, JH	1
Cross, AJ; Deakin, JF; Perry, EK; Perry, RH; Royston, C; Simpson, M; Slater, P	1
Meldrum, B	1
Amsler, U; Cuénod, M; Perschak, H; Siegfried, J; Vischer, A	1

Reviews

6 review(s) available for aspartic acid and Idiopathic Parkinson Disease

Article	Year
Magnetic resonance spectroscopy: an in vivo molecular imaging biomarker for Parkinson's disease? BioMed research international, 2014, Volume: 2014 Topics: Aspartic Acid; Biomarkers; Brain; Choline; Creatine; Humans; Magnetic Resonance Spectroscopy; Molecular Imaging; Parkinson Disease; Reproducibility of Results; Sensitivity and Specificity	2014
Parkinson's disease: oxidative stress and therapeutic approaches. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2010, Volume: 31, Issue:5 Topics: Animals; Antioxidants; Aspartic Acid; Brain; Catecholamines; Humans; Lipid Peroxidation; Nitric Oxide; Oxidative Stress; Parkinson Disease; Proteasome Endopeptidase Complex; Ubiquitins	2010
A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease. Dementia and geriatric cognitive disorders, 2002, Volume: 14, Issue:2 Topics: Alzheimer Disease; Aspartic Acid; Brain; Choline; Humans; Inositol; Magnetic Resonance Spectroscopy; Parkinson Disease; Reference Values; Temporal Lobe	2002
[Magnetic resonance spectroscopy in Parkinson's disease and multiple system atrophy]. Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55, Issue:1 Topics: Aspartic Acid; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Brain; Choline; Creatine; Diagnosis, Differential; Humans; Magnetic Resonance Spectroscopy; Parkinson Disease; Protons	1997
Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease. Trends in neurosciences, 1990, Volume: 13, Issue:7 Topics: Animals; Anticonvulsants; Aspartic Acid; Basal Ganglia; Biogenic Amines; Dibenzocycloheptenes; Dizocilpine Maleate; Glutamates; Glutamic Acid; Humans; N-Methylaspartate; Parkinson Disease; Schizophrenia	1990
Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. Clinical science (London, England : 1979), 1985, Volume: 68, Issue:2 Topics: Alzheimer Disease; Animals; Aspartic Acid; Basal Ganglia Diseases; Brain; Brain Ischemia; Epilepsy; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Humans; Huntington Disease; Mice; Movement Disorders; Nerve Degeneration; Neurotransmitter Agents; Parkinson Disease; Rats	1985

Trials

7 trial(s) available for aspartic acid and Idiopathic Parkinson Disease

Article	Year
Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial. Journal of psychopharmacology (Oxford, England), 2014, Volume: 28, Issue:11 Topics: Aged; Aged, 80 and over; Aspartic Acid; Brain-Derived Neurotrophic Factor; Cannabidiol; Creatine; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease; Proton Magnetic Resonance Spectroscopy; Putamen; Quality of Life; Severity of Illness Index; Treatment Outcome	2014
MRS study on lentiform nucleus in idiopathic Parkinson's disease with unilateral symptoms. Journal of Zhejiang University. Science, 2004, Volume: 5, Issue:2 Topics: Aged; Aspartic Acid; Biomarkers; Choline; Corpus Striatum; Creatine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; Reproducibility of Results; Sensitivity and Specificity	2004
Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker. Journal of neurology, neurosurgery, and psychiatry, 2004, Volume: 75, Issue:1 Topics: Aspartic Acid; Brain Stem; Case-Control Studies; Cerebral Cortex; Creatine; Diagnosis, Differential; Female; Humans; Hydrogen; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Putamen; Reference Values	2004
Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study. Movement disorders : official journal of the Movement Disorder Society, 2007, Nov-15, Volume: 22, Issue:15 Topics: Adult; Aged; Aspartic Acid; Choline; Creatinine; Dopamine Agonists; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Parkinson Disease; Pergolide; Protons; Treatment Outcome	2007
1H-MRS experiences after bilateral DBS of the STN in Parkinson's disease. Parkinsonism & related disorders, 2008, Volume: 14, Issue:3 Topics: Aged; Aspartic Acid; Choline; Creatine; Deep Brain Stimulation; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; Protons; Subthalamic Nucleus	2008
Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study. Magnetic resonance in medicine, 1995, Volume: 33, Issue:5 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antiparkinson Agents; Aspartic Acid; Carbidopa; Choline; Corpus Striatum; Dopamine Agonists; Drug Combinations; Female; Humans; Levodopa; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; Pilot Projects; Protons	1995
Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy. Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 62, Issue:3 Topics: Aged; Aspartic Acid; Corpus Striatum; Creatine; Globus Pallidus; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Parkinson Disease; Phosphocreatine; Putamen; Statistics, Nonparametric; Supranuclear Palsy, Progressive	1997

Other Studies

71 other study(ies) available for aspartic acid and Idiopathic Parkinson Disease

Article	Year
Magnetic resonance spectroscopy shows associations between neurometabolite levels and perivascular space volume in Parkinson's disease: a pilot and feasibility study. Neuroreport, 2022, 05-04, Volume: 33, Issue:7 Topics: Aspartic Acid; Brain; Creatine; Feasibility Studies; Humans; Inflammation; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Parkinson Disease; Pilot Projects	2022
L-Ornithine L-Aspartate Restores Mitochondrial Function and Modulates Intracellular Calcium Homeostasis in Parkinson's Disease Models. Cells, 2022, 09-17, Volume: 11, Issue:18 Topics: Aspartic Acid; Calcium; Dipeptides; Dopaminergic Neurons; Fluorescent Dyes; Homeostasis; Humans; Mitochondria; Neuroblastoma; Ornithine; Oxidopamine; Parkinson Disease; Reactive Oxygen Species; Rotenone	2022
Primary motor area-related injury of anterior central gyrus in Parkinson's disease with dyskinesia: A study based on MRS and Q-space. Neuroscience letters, 2023, 05-14, Volume: 805 Topics: Aspartic Acid; Brain; Choline; Creatine; Dyskinesias; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Motor Cortex; Parkinson Disease	2023
Profiles of brain oxidative damage, ventricular alterations, and neurochemical metabolites in the striatum of PINK1 knockout rats as functions of age and gender: Relevance to Parkinson disease. Free radical biology & medicine, 2019, 11-01, Volume: 143 Topics: Animals; Aspartic Acid; Biomarkers; Brain; Corpus Striatum; Disease Models, Animal; Female; Gene Knockout Techniques; Glutamine; Glutathione; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Neurodegenerative Diseases; Oxidative Stress; Parkinson Disease; Protein Kinases; Rats; Taurine	2019
Frontal lobe metabolic alterations characterizing Parkinson's disease cognitive impairment. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021, Volume: 42, Issue:3 Topics: Aspartic Acid; Brain; Cognitive Dysfunction; Creatine; Frontal Lobe; Gray Matter; Humans; Magnetic Resonance Imaging; Parkinson Disease	2021
Thalamic neurometabolic alterations in tremulous Parkinson's disease: A preliminary proton MR spectroscopy study. Parkinsonism & related disorders, 2017, Volume: 43 Topics: Aged; Aspartic Acid; Choline; Creatine; Discriminant Analysis; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Logistic Models; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; ROC Curve; Thalamus; Tomography, Emission-Computed, Single-Photon; Tremor	2017
Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study. Journal of Alzheimer's disease : JAD, 2017, Volume: 60, Issue:4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Biomarkers; Cognitive Dysfunction; Disease Progression; Female; Follow-Up Studies; Gyrus Cinguli; Humans; Inositol; Lewy Body Disease; Male; Mental Status and Dementia Tests; Parkinson Disease; Prodromal Symptoms; Proton Magnetic Resonance Spectroscopy; Retrospective Studies; Risk Factors	2017
Proposed biochemistry of Parkinson's and Alzheimer's diseases. Medical hypotheses, 2017, Volume: 109 Topics: Aldehydes; Alzheimer Disease; Aspartic Acid; Betaine; Brain; Disease Progression; Humans; Kynurenine; Lewy Bodies; Models, Biological; Parkinson Disease; Plaque, Amyloid; Pyruvaldehyde; Quinolinic Acid; Treatment Outcome	2017
Dopamine reduction in the substantia nigra of Parkinson's disease patients confirmed by in vivo magnetic resonance spectroscopic imaging. PloS one, 2014, Volume: 9, Issue:1 Topics: Aged; Aspartic Acid; Case-Control Studies; Choline; Creatine; Dopamine; Humans; Magnetic Resonance Imaging; Middle Aged; Parkinson Disease; Substantia Nigra	2014
Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study. Neuroscience letters, 2015, Jul-10, Volume: 599 Topics: Antiparkinson Agents; Aspartic Acid; Case-Control Studies; Choline; Creatine; Dopamine Agonists; Female; Humans; Indoles; Magnetic Resonance Imaging; Male; Middle Aged; Motor Cortex; Parkinson Disease; Proton Magnetic Resonance Spectroscopy	2015
MR Spectroscopy: A Longitudinal Biomarker for Substantia Nigra Pathology in Parkinson's Disease? Movement disorders : official journal of the Movement Disorder Society, 2015, Volume: 30, Issue:10 Topics: Aspartic Acid; Creatine; Female; Humans; Male; Parkinson Disease; Proton Magnetic Resonance Spectroscopy; Substantia Nigra	2015
Longitudinal study of the substantia nigra in Parkinson disease: A high-field (1) H-MR spectroscopy imaging study. Movement disorders : official journal of the Movement Disorder Society, 2015, Volume: 30, Issue:10 Topics: Aged; Aspartic Acid; Biomarkers; Creatine; Female; Humans; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Proton Magnetic Resonance Spectroscopy; Substantia Nigra	2015
Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting. Parkinsonism & related disorders, 2016, Volume: 22 Topics: Aged; Aged, 80 and over; Aspartic Acid; Bayes Theorem; Case-Control Studies; Choline; Cognitive Dysfunction; Creatine; Dementia; Disease Progression; Female; Gyrus Cinguli; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Superior Sagittal Sinus	2016
Proton MR Spectroscopy for Monitoring Pathologic Changes in the Substantia Nigra and Globus Pallidus in Parkinson Disease. AJR. American journal of roentgenology, 2016, Volume: 206, Issue:2 Topics: Aged; Aspartic Acid; Creatine; Female; Globus Pallidus; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; Protons; Retrospective Studies; Severity of Illness Index; Substantia Nigra	2016
Parkinson patient fibroblasts show increased alpha-synuclein expression. Experimental neurology, 2008, Volume: 212, Issue:2 Topics: Aged; alpha-Synuclein; Aspartic Acid; Cells, Cultured; Family Health; Female; Fibroblasts; Gene Expression Regulation; Glycine; Humans; Male; Middle Aged; Mitochondria; Mutation; Parkinson Disease; Protein Kinases; Time Factors	2008
Molecular analysis of the parkin gene in South African patients diagnosed with Parkinson's disease. Parkinsonism & related disorders, 2009, Volume: 15, Issue:2 Topics: Adolescent; Adult; Aged; Arginine; Asparagine; Aspartic Acid; Cysteine; DNA Mutational Analysis; Exons; Female; Gene Frequency; Heterozygote; Humans; Male; Middle Aged; Parkinson Disease; Point Mutation; Sequence Deletion; South Africa; Ubiquitin-Protein Ligases; Young Adult	2009
Intact presupplementary motor area function in early, untreated Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2008, Sep-15, Volume: 23, Issue:12 Topics: Aged; Aspartic Acid; Case-Control Studies; Choline; Creatine; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Parkinson Disease	2008
Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2008, Volume: 4, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Aspartic Acid; Case-Control Studies; Choline; Creatine; Glutamic Acid; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Mental Status Schedule; Middle Aged; Nootropic Agents; Parkinson Disease	2008
Alpha-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease. Journal of neuropathology and experimental neurology, 2009, Volume: 68, Issue:5 Topics: Alanine; alpha-Synuclein; Animals; Aspartic Acid; Basal Ganglia; Cell Count; Dependovirus; Disease Models, Animal; Dopamine; Green Fluorescent Proteins; Humans; Mutation; Nerve Tissue Proteins; Parkinson Disease; Phosphorylation; Rats; Rats, Sprague-Dawley; Serine; Substantia Nigra; Tyrosine 3-Monooxygenase	2009
Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. European journal of neurology, 2010, Volume: 17, Issue:9 Topics: Aged; Aspartic Acid; Basal Ganglia Diseases; Biomarkers; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple System Atrophy; Neurons; Parkinson Disease; Predictive Value of Tests; Supranuclear Palsy, Progressive	2010
Symptomatic and neuroprotective effects following activation of nigral group III metabotropic glutamate receptors in rodent models of Parkinson's disease. British journal of pharmacology, 2010, Volume: 160, Issue:7 Topics: Aminobutyrates; Animals; Aspartic Acid; Disease Models, Animal; Excitatory Amino Acid Agonists; Glutamic Acid; Immunohistochemistry; Male; Microdialysis; Motor Activity; Neuroprotective Agents; Parkinson Disease; Phosphoserine; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Substantia Nigra	2010
Three-dimensional magnetic resonance spectroscopic imaging in the substantia nigra of healthy controls and patients with Parkinson's disease. European radiology, 2011, Volume: 21, Issue:9 Topics: Aged; Aspartic Acid; Case-Control Studies; Choline; Creatine; Female; Humans; Imaging, Three-Dimensional; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; Reference Values; Sensitivity and Specificity; Severity of Illness Index; Substantia Nigra	2011
Magnetic resonance spectroscopic methods for the assessment of metabolic functions in the diseased brain. Current topics in behavioral neurosciences, 2012, Volume: 11 Topics: Alzheimer Disease; Aspartic Acid; Brain; Humans; Isotopes; Magnetic Resonance Spectroscopy; Parkinson Disease; Protons	2012
Vacuolar protein sorting 35 Asp620Asn mutation is rare in the ethnic Chinese population with Parkinson's disease. Parkinsonism & related disorders, 2012, Volume: 18, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Asparagine; Aspartic Acid; China; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Mutation; Parkinson Disease; Vesicular Transport Proteins	2012
GBA-associated PD. Neurodegeneration, altered membrane metabolism, and lack of energy failure. Neurology, 2012, Jul-17, Volume: 79, Issue:3 Topics: Adenosine Diphosphate; Adult; Age of Onset; Aged; Algorithms; Aspartic Acid; Brain Chemistry; Choline; Creatine; DNA; Energy Metabolism; Female; Glucosylceramidase; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Membranes; Middle Aged; Mitochondria; Nerve Degeneration; Neurons; Parkinson Disease; Phospholipids; Software	2012
Anterior cingulate integrity: executive and neuropsychiatric features in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2012, Sep-01, Volume: 27, Issue:10 Topics: Aged; Aspartic Acid; Case-Control Studies; Cognition Disorders; Creatine; Female; Gyrus Cinguli; Humans; Linear Models; Magnetic Resonance Spectroscopy; Male; Mental Disorders; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Parkinson Disease	2012
Unusual basal ganglia lesions in a diabetic uraemic patient proven to be demyelination: first pathological observation. BMJ case reports, 2012, Sep-03, Volume: 2012 Topics: Aspartic Acid; Basal Ganglia; Basal Ganglia Diseases; Demyelinating Diseases; Diabetic Nephropathies; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Follow-Up Studies; Humans; Japan; Macrophages; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Myelinolysis, Central Pontine; Neurologic Examination; Parkinson Disease; Putamen; Shock, Septic; Uremia	2012
VPS35 mutation in Japanese patients with typical Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2012, Sep-15, Volume: 27, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asian People; Asparagine; Aspartic Acid; Child; Disability Evaluation; Family Health; Female; Genetic Predisposition to Disease; Genetic Testing; Haplotypes; Humans; Male; Middle Aged; Mutation; Parkinson Disease; Vesicular Transport Proteins; Young Adult	2012
Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease. Dementia and geriatric cognitive disorders, 2012, Volume: 34, Issue:5-6 Topics: Aged, 80 and over; Aspartic Acid; Brain Chemistry; Cognition; Cognitive Dysfunction; Data Interpretation, Statistical; Dementia; Disease Progression; Executive Function; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Prefrontal Cortex; Psychiatric Status Rating Scales; Psychomotor Performance; Temporal Lobe; Tomography, X-Ray Computed	2012
Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment. Parkinsonism & related disorders, 2013, Volume: 19, Issue:3 Topics: Aged; Aspartic Acid; Biomarkers; Brain; Brain Chemistry; Choline; Cognitive Dysfunction; Early Diagnosis; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease	2013
VPS35 Asp620Asn and EIF4G1 Arg1205His mutations are rare in Parkinson disease from southwest China. Neurobiology of aging, 2013, Volume: 34, Issue:6 Topics: Adult; Aged; Arginine; Asparagine; Aspartic Acid; Case-Control Studies; China; Eukaryotic Initiation Factor-4G; Female; Histidine; Humans; Male; Middle Aged; Mutation; Parkinson Disease; Vesicular Transport Proteins; Young Adult	2013
Applications of neural network analyses to in vivo 1H magnetic resonance spectroscopy of Parkinson disease patients. Journal of magnetic resonance imaging : JMRI, 2002, Volume: 16, Issue:1 Topics: Aged; Aspartic Acid; Basal Ganglia; Case-Control Studies; Choline; Creatine; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neural Networks, Computer; Parkinson Disease	2002
Why Rome trembles: "E avanti a lui tremava tutta Roma!" (Tosca, Act II). Neurology, 2003, Apr-22, Volume: 60, Issue:8 Topics: Aspartic Acid; Cerebellum; Choline; Creatine; Essential Tremor; Humans; Magnetic Resonance Spectroscopy; Parkinson Disease; Raphe Nuclei; Receptor, Serotonin, 5-HT1A; Tomography, Emission-Computed	2003
The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis. The European journal of neuroscience, 2003, Volume: 18, Issue:4 Topics: Adrenergic Agents; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Aspartic Acid; Basal Ganglia; Chromatography, High Pressure Liquid; Excitatory Amino Acid Agonists; gamma-Aminobutyric Acid; Glutamic Acid; Immunohistochemistry; Injections, Intraventricular; Kainic Acid; Male; Microdialysis; Models, Animal; Oxidopamine; Parkinson Disease; Potassium; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase	2003
Proton MR spectroscopic changes in Parkinson's diseases after thalamotomy. European journal of radiology, 2003, Volume: 47, Issue:3 Topics: Adult; Aspartic Acid; Brain; Choline; Creatine; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; Postoperative Period; Protons; Stereotaxic Techniques; Thalamus; Treatment Outcome; Tremor	2003
Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia. Neuroscience letters, 2004, Jan-16, Volume: 354, Issue:3 Topics: Aged; Aspartic Acid; Case-Control Studies; Choline; Cognition; Creatine; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mental Status Schedule; Middle Aged; Parkinson Disease	2004
Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:1 Topics: Aged; Alleles; Aspartic Acid; DNA Mutational Analysis; Female; Gene Frequency; Genotype; Glucosylceramidase; Humans; Jews; Linkage Disequilibrium; Male; Middle Aged; Parkinson Disease; Pilot Projects; Point Mutation; Serine	2005
Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nature neuroscience, 2005, Volume: 8, Issue:5 Topics: alpha-Synuclein; Amino Acid Substitution; Animals; Animals, Genetically Modified; Aspartic Acid; beta-Adrenergic Receptor Kinases; Brain; Central Nervous System; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Dopamine; Drosophila; Drosophila Proteins; G-Protein-Coupled Receptor Kinase 2; Inclusion Bodies; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Parkinson Disease; Phosphorylation; Point Mutation; Retina; Serine; Synucleins	2005
8-hydroxy-2-(di-n-propylamino)tetralin reduces striatal glutamate in an animal model of Parkinson's disease. Neuroreport, 2005, May-12, Volume: 16, Issue:7 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Aspartic Acid; Corpus Striatum; Denervation; Disease Models, Animal; Glutamic Acid; Injections, Subcutaneous; Male; Microdialysis; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Receptor Agonists; Sympatholytics	2005
Brainstem 1H-MR spectroscopy in patients with Parkinson's disease with REM sleep behavior disorder and IPD patients without dream enactment behavior. Clinical neurology and neurosurgery, 2006, Volume: 108, Issue:2 Topics: Aged; Aspartic Acid; Brain Stem; Case-Control Studies; Choline; Creatine; Female; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; Prospective Studies; REM Sleep Behavior Disorder	2006
Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations. Magnetic resonance in medicine, 2006, Volume: 55, Issue:2 Topics: Aspartic Acid; Feasibility Studies; gamma-Aminobutyric Acid; Glutamic Acid; Glutathione; Humans; Magnetic Resonance Spectroscopy; Parkinson Disease; Protons; Substantia Nigra	2006
Screening for mutations of the HFE gene in Parkinson's disease patients with hyperechogenicity of the substantia nigra. Neuroscience letters, 2006, Oct-16, Volume: 407, Issue:1 Topics: Aged; Aspartic Acid; Chromatography, High Pressure Liquid; DNA Mutational Analysis; Exons; Female; Gene Frequency; Genetic Testing; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Isoleucine; Male; Membrane Proteins; Middle Aged; Mucoproteins; Mutation; Parkinson Disease; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substantia Nigra; Threonine	2006
Glutamate measurement in Parkinson's disease using MRS at 3 T field strength. NMR in biomedicine, 2007, Volume: 20, Issue:8 Topics: Antiparkinson Agents; Aspartic Acid; Corpus Striatum; Creatine; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Levodopa; Magnetic Resonance Spectroscopy; Parkinson Disease; Reference Values	2007
HFE gene mutations in a population of Italian Parkinson's disease patients. Parkinsonism & related disorders, 2008, Volume: 14, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Cysteine; DNA Mutational Analysis; Female; Gene Frequency; Genotype; Hemochromatosis Protein; Histidine; Histocompatibility Antigens Class I; Humans; Italy; Male; Membrane Proteins; Middle Aged; Mutation; Parkinson Disease; Serine	2008
Excitatory amino acid receptors. Progress in clinical and biological research, 1981, Volume: 68 Topics: Animals; Aspartic Acid; Binding Sites; Brain; Glutamates; Glutamic Acid; Humans; Kainic Acid; Kinetics; Neurons; Parkinson Disease; Protein Conformation; Receptors, Cell Surface; Receptors, Glutamate; Receptors, Neurotransmitter; Spinal Cord	1981
Oral glutamate loading in disorders with spinocerebellar and extrapyramidal involvement: effect on plasma glutamate, aspartate and taurine. Journal of neural transmission. Supplementum, 1983, Volume: 19 Topics: Aspartic Acid; Atrophy; Basal Ganglia Diseases; Cerebellar Diseases; Cerebellum; Friedreich Ataxia; Glutamate Dehydrogenase; Glutamates; Glutamic Acid; Humans; Nerve Degeneration; Olivary Nucleus; Parkinson Disease; Pons; Shy-Drager Syndrome; Sodium Glutamate; Spinal Cord Diseases; Taurine	1983
[GABA, glutamate, aspartate, glycine, and taurine contents in spinocerebellar degeneration and parkinsonism]. Rinsho shinkeigaku = Clinical neurology, 1984, Volume: 24, Issue:3 Topics: Adult; Aged; Amino Acids; Aspartic Acid; Brain Chemistry; Cerebellar Ataxia; Chromatography, High Pressure Liquid; Female; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Humans; Male; Middle Aged; Neurotransmitter Agents; Parkinson Disease; Taurine	1984
Magnetic resonance spectroscopic study of parkinsonism related to boxing. Journal of neurology, neurosurgery, and psychiatry, 1995, Volume: 58, Issue:6 Topics: Aged; Aspartic Acid; Boxing; Corpus Striatum; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease	1995
Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy. Annals of neurology, 1995, Volume: 37, Issue:2 Topics: Adult; Aged; Aspartic Acid; Atrophy; Basal Ganglia; Brain Diseases; Choline; Creatine; Diagnosis, Differential; Globus Pallidus; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Parkinson Disease; Protons; Putamen	1995
Proton magnetic resonance spectroscopy in suspected vascular ischemic parkinsonism. Acta neurologica Scandinavica, 1994, Volume: 90, Issue:6 Topics: Aged; Aspartic Acid; Brain; Brain Ischemia; Brain Mapping; Energy Metabolism; Female; Humans; Intracranial Arteriosclerosis; Lactates; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nerve Degeneration; Parkinson Disease; Regional Blood Flow	1994
Proton MR spectroscopy of the brain in 14 patients with Parkinson disease. AJNR. American journal of neuroradiology, 1995, Volume: 16, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain; Choline; Creatine; Dementia; Energy Metabolism; Female; Humans; Lactates; Levodopa; Magnetic Resonance Spectroscopy; Male; Middle Aged; Occipital Lobe; Oxidation-Reduction; Parkinson Disease; Phosphocreatine; Protons	1995
MRS to differentiate multiple system atrophy from idiopathic Parkinson's disease. Lancet (London, England), 1993, Sep-11, Volume: 342, Issue:8872 Topics: Adult; Aged; Aspartic Acid; Basal Ganglia; Central Nervous System Diseases; Creatine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease	1993
Proton magnetic resonance spectroscopy with dementia. Surgical neurology, 1993, Volume: 39, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Creatine; Dementia; Female; Humans; Hydrocephalus, Normal Pressure; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; Protons; Reference Values	1993
Magnetic resonance spectroscopic study of parkinsonism related to boxing. Journal of neurology, neurosurgery, and psychiatry, 1995, Volume: 59, Issue:5 Topics: Aspartic Acid; Boxing; Humans; Magnetic Resonance Spectroscopy; Parkinson Disease; Pilot Projects	1995
Neurotransmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease. Journal of the neurological sciences, 1996, Sep-15, Volume: 141, Issue:1-2 Topics: Aged; Amino Acids; Asparagine; Aspartic Acid; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Glycine; Humans; Male; Middle Aged; Neurotransmitter Agents; Parkinson Disease	1996
Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy. Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:3 Topics: Aged; Apomorphine; Aspartic Acid; Basal Ganglia; Choline; Creatine; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Parkinson Disease	1997
Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study. Neurology, 1997, Volume: 49, Issue:2 Topics: Adult; Aged; Antiparkinson Agents; Aspartic Acid; Choline; Creatine; Dopamine Agents; Humans; Levodopa; Magnetic Resonance Spectroscopy; Middle Aged; Parkinson Disease; Phosphocreatine; Protons; Putamen; Reference Values	1997
Proton MR spectroscopic imaging of the striatum in Parkinson's disease. Magnetic resonance imaging, 1997, Volume: 15, Issue:6 Topics: Adult; Aged; Aspartic Acid; Biomarkers; Choline; Corpus Striatum; Creatine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Thalamus	1997
Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain : a journal of neurology, 1997, Volume: 120 ( Pt 9) Topics: Aged; Aged, 80 and over; Aspartic Acid; Brain; Brain Diseases; Choline; Creatine; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nerve Degeneration; Parkinson Disease; Phosphocreatine; Protons; Supranuclear Palsy, Progressive; Tissue Distribution	1997
Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders. Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:6 Topics: Aged; Antiparkinson Agents; Aspartic Acid; Atrophy; Cerebral Cortex; Choline; Corpus Striatum; Creatinine; Female; Globus Pallidus; Humans; Levodopa; Magnetic Resonance Spectroscopy; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Phosphocreatine; Protons; Putamen; Supranuclear Palsy, Progressive	1997
Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy. Investigative radiology, 1998, Volume: 33, Issue:8 Topics: Adult; Aged; Aspartic Acid; Brain Chemistry; Choline; Creatine; Female; Globus Pallidus; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; Putamen; Substantia Nigra	1998
Immunohistochemical localization of amyloid beta-protein with amino-terminal aspartate in the cerebral cortex of patients with Alzheimer's disease. Brain research, 1999, Mar-27, Volume: 823, Issue:1-2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aspartic Acid; Cerebral Cortex; Down Syndrome; Humans; Immunohistochemistry; Parkinson Disease; Tissue Distribution	1999
A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease. Metabolic brain disease, 1999, Volume: 14, Issue:1 Topics: Aged; Aspartic Acid; Cerebral Cortex; Choline; Corpus Striatum; Creatine; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Movement Disorders; Parietal Lobe; Parkinson Disease; Reference Values; Temporal Lobe	1999
In vivo magnetic resonance spectroscopy of human fetal neural transplants. NMR in biomedicine, 1999, Volume: 12, Issue:4 Topics: Adult; Aspartic Acid; Brain; Fetal Tissue Transplantation; Humans; Huntington Disease; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Parkinson Disease	1999
The brain lesion responsible for parkinsonism after carbon monoxide poisoning. Archives of neurology, 2000, Volume: 57, Issue:8 Topics: Aspartic Acid; Brain Chemistry; Carbon Monoxide Poisoning; Carrier Proteins; Choline; Cognition Disorders; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Phosphocreatine; Tomography, Emission-Computed, Single-Photon	2000
Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy. European journal of neurology, 2000, Volume: 7, Issue:6 Topics: Adult; Aged; Aspartic Acid; Basal Ganglia; Choline; Creatine; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pilot Projects; Reference Values	2000
Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2001, Volume: 22, Issue:1 Topics: Aged; Aspartic Acid; Basal Ganglia; Brain Chemistry; Choline; Creatine; Female; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Parkinson Disease	2001
Increased plasma concentrations of aspartate, glutamate and glycine in Parkinson's disease. Neuroscience letters, 1992, Oct-12, Volume: 145, Issue:2 Topics: Aged; Aged, 80 and over; Aspartic Acid; Female; Glutamates; Glutamic Acid; Glycine; Humans; Male; Middle Aged; Parkinson Disease	1992
Distribution of neurofibrillary tangle formation and [3H]-D-aspartate receptor binding in the thalamus in the normal elderly brain, in Alzheimer's disease and in Parkinson's disease. Neuropathology and applied neurobiology, 1990, Volume: 16, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Autoradiography; Female; Humans; Male; Neurons; Parkinson Disease; Receptors, Amino Acid; Receptors, Cell Surface; Reference Values; Thalamus; Tritium	1990
Sodium dependent D-[3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases. Neuroscience letters, 1987, Aug-18, Volume: 79, Issue:1-2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Cerebral Cortex; Choline O-Acetyltransferase; Humans; In Vitro Techniques; Kinetics; Parkinson Disease; Receptors, Glutamate; Receptors, Neurotransmitter; Sodium	1987
Ventricular cerebrospinal fluid concentrations of putative amino acid transmitters in Parkinson's disease and other disorders. Human neurobiology, 1987, Volume: 6, Issue:3 Topics: Adult; Aged; Amino Acids; Aspartic Acid; Ethanolamine; Ethanolamines; Female; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Glycine; Humans; Male; Middle Aged; Neurotransmitter Agents; Parkinson Disease; Proline; Tremor	1987